Echo IQ:
Designed FOR

Echo IQ harnesses the power of echocardiographic measurement data to improve diagnosis of structural heart disease.

0 %
of all deaths worldwide attributed to cardiovascular disease
0 in 2
people with heart valve disease don’t know they’ve got it
0 years
mortality rate for untreated symptomatic severe aortic stenosis

We combine innovative AI techniques and access to the world’s leading echo cardiographic database linked to mortality


Improves diagnostic performance, detecting 100% of patients within severe aortic stenosis clinical guidelines.

Earlier Diagnosis
Facilitates accurate and early diagnosis of at-risk patients with the identification of a severe AS phenotype.

Zero Bias
Standardised more equitable AI-backed diagnosis across genders, age and background.

Improved Access to Care Identifying more at-risk patients increases opportunities to treat, benefiting both patients and healthcare professionals. Improved Health Outcomes Earlier diagnosis can lead to earlier intervention, reducing time-to-treatment for appropriate patients. Improved Quality Outcomes EchoSolv allows for retrospective review of historical records and real-time analysis of current echocardiograms.
Applying AI to support improved detection of this increasingly prevalent condition.
Delayed treatment costs lives and 6 month mortality rates are 3x those at 1 month.

Request A Demo
Developing solutions to improve identification of systolic and diastolic dysfunction.
The prevalence of heart failure is increasing as people live longer, with more than 6M Americans directly affected.

Request A Demo
Developing new solutions to enhance detection, and treatment.

Intervention shown to decrease risk of future hospitalisation and improve quality of life.

Request A Demo

At Echo IQ our mission is to help support
earlier access to lifesaving and enhancing
treatments and therapies for various forms of
structural heart disease. We pride ourselves
on helping physicians and clinicians get to the
heart of the matter quickly and simply.

Echo IQ’s solutions are being designed to give
healthcare practitioners additional tools that
help them avoid misdiagnosis of
treatable conditions.

0 in 5
Aortic stenosis is estimated to affect more than 20% of people who are over 65 years old
0 million
Providing diagnostic solutions for a disease that kills 18 million people each year
Backed by leading cardiac data
EchoSolv has been developed using what we believe to be the largest database of its kind anywhere in the world.  Echo IQ has secured exclusive commercial access to the National Echocardiographic Database of Australia (NEDA). NEDA is a highly trusted and respected research database that collects echocardiographic measurements and associated health information from more than 35 leading hospitals.
0 M
With over 200 million data points, NEDA provides accurate and important data for diagnosis.
Over 0 M
We have access to more than 2M cardiac patient records.
0 M Deaths
Helping provide diagnostic solutions for a disease that kills 18 million people each year.​
Cardiologist and Researcher

The use of large cardiac datasets to develop solutions that advance risk detection for increasingly treatable conditions is incredibly exciting.


The application of new techniques such as machine learning and artificial intelligence to the world of cardiology creates significant opportunity to deliver meaningful improvements in diagnosis and treatment.

Public health leader

Applying new digital technologies to the detection and treatment of cardiovascular diseases has the potential to change the way we approach public healthcare delivery

Leading Cardiovascular Researcher and Physician

The work being undertaken by Echo IQ utilizes novel approaches to the diagnosis of cardiovascular diseases that could potentially open treatment avenues for those in greatest need. The convergence of artificial intelligence, machine learning and novel techniques in echocardiography is incredibly exciting.

Echo IQ is proudly influenced by research innovation, commercial opportunity
and improving health outcomes.

Let’s start a conversation.